Revista Peruana de Medicina Experimental y Salud Pública (Aug 2021)

Frequency of community-acquired methicilin-resistant Staphylococcus aureus in a tertiary care hospital in Peru

  • Lucía Cabrejos-Hirashima,
  • Camila Vives-Kufoy,
  • Jaycia Inga-Salazar,
  • Lizeth Astocondor,
  • Noemi Hinostroza,
  • Coralith García

DOI
https://doi.org/10.17843/rpmesp.2021.382.6867
Journal volume & issue
Vol. 38, no. 2
pp. 313 – 7

Abstract

Read online

In order to determine the frequency of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) isolates and to describe the antimicrobial resistance pattern and genotype, a cross-sectional study was conducted in 2017 at the Hospital Nacional Cayetano Heredia in Lima, Peru. We found a MRSA prevalence of 46.1% in the 115 analyzed S. aureus isolates; most were reported from different secretions (26.4%) and blood (18.9%). We found high co-resistance (75%) to clindamycin, erythromycin, gentamicin and ciprofloxacin. Regarding SSCmec typification, most of the isolates were identified as hospital-acquired MRSA (HA-MRSA) and a minority of them as CA-MRSA (2.6%). Despite its low prevalence when compared to other Latin American countries (27%), epidemiological surveillance is recommended to control local CA-MRSA dissemination.

Keywords